Tag Archives: Elie Wiesel

Ethics in Drug Innovation: The First Hurdle is Trust

By Guest Blogger | Published: October 19, 2012

By Ansis Helmanis Ethics is a matter of trust, which in the regulatory space requires transparency and openness among all stakeholders, including patients and industry. This was the consensus of FDA Commissioner Margaret Hamburg and European Medicines Agency (EMA) Executive Director Guido Rasi, both of whom shared the podium with Nobel Laureate Professor Elie Wiesel [...]

Posted in Europe, Events, FDA, Global, Guest Blog, Market Access, Patient Communication, Regulatory, healthcare, leadership, pricing | Also tagged CMS, EMA, FDA, Guido Rasi, Margaret Hamburg, Prix Galien, reimbursement, sequestration | Leave a comment

Pharma Celebrates its Own

By Andrew Sheivachman | Published: October 7, 2009

At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage. “The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon Health [...]

Posted in Events | Also tagged American Museum of Natural History, business, Clinical trial, Columbia University, GlaxoSmithKline, Harvard School of Public Health, Health, Health care, Jeffrey Sachs, Pharmaceutical drug, Prix Galien, Public health, United States | Leave a comment

Simply Genius: Prix Galien USA 2008 (photos)

By George Koroneos | Published: September 25, 2008

Click here to view a slideshow from Prix Galien 2008 The 2008 Prix Galien USA is in the books, and Pharm Exec was in attendance at New York’s Museum of Natural History to take in all the festivities. Pfizer, Merck, Alexion, Wyeth, and Celgene were all recognized for their work in advancing science in both the [...]

Posted in Biotech, Events, People | Also tagged Alexion, Biotech, Celgene, Charlie Rose, Merck, Pfizer, Prix Galien, Wyeth | Leave a comment